Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Cytek Biosciences (CTKB) Other Operating Expenses (2020 - 2025)

Historic Other Operating Expenses for Cytek Biosciences (CTKB) over the last 6 years, with Q3 2025 value amounting to $11.7 million.

  • Cytek Biosciences' Other Operating Expenses fell 613.89% to $11.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $48.2 million, marking a year-over-year decrease of 126.64%. This contributed to the annual value of $49.1 million for FY2024, which is 6.92% down from last year.
  • Per Cytek Biosciences' latest filing, its Other Operating Expenses stood at $11.7 million for Q3 2025, which was down 613.89% from $12.1 million recorded in Q2 2025.
  • Cytek Biosciences' Other Operating Expenses' 5-year high stood at $12.5 million during Q1 2024, with a 5-year trough of -$6.2 million in Q1 2023.
  • In the last 5 years, Cytek Biosciences' Other Operating Expenses had a median value of $9.0 million in 2022 and averaged $7.2 million.
  • Per our database at Business Quant, Cytek Biosciences' Other Operating Expenses crashed by 22668.62% in 2023 and then surged by 37531.42% in 2024.
  • Over the past 5 years, Cytek Biosciences' Other Operating Expenses (Quarter) stood at $8.3 million in 2021, then grew by 8.73% to $9.0 million in 2022, then rose by 28.04% to $11.6 million in 2023, then increased by 2.71% to $11.9 million in 2024, then fell by 1.75% to $11.7 million in 2025.
  • Its Other Operating Expenses was $11.7 million in Q3 2025, compared to $12.1 million in Q2 2025 and $12.5 million in Q1 2025.